Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs EDETATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs EDETATE: Safety Overview

Metric ECULIZUMAB EDETATE
Total FAERS Reports 44,190 145
Deaths Reported 4,626 9
Death Rate 10.5% 6.2%
Hospitalizations 12,421 107
Average Patient Age 42.6 yrs 58.2 yrs
% Female Patients 59.5% 51.1%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Alexion Pharmaceuticals Inc. Rising Pharma Holdings, Inc.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Prescription Discontinued